Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars.
about
The Diversity of Biosimilar Design and Development: Implications for Policies and StakeholdersThe introduction of biosimilars of low molecular weight heparins in Europe: a critical review and reappraisal endorsed by the Italian Society for Haemostasis and Thrombosis (SISET) and the Italian Society for Angiology and Vascular Medicine (SIAPAV)Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary names.Pharmacovigilance Considerations for Biosimilars in the USAEvaluating AE Reporting of Two Off-Patent Biologics to Inform Future Biosimilar Naming and Reporting Practices.The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study.Equivalence of complex drug products: advances in and challenges for current regulatory frameworks.Equivalence of glatiramer acetate products: challenges in assessing pharmaceutical equivalence and critical clinical performance attributes.
P2860
Q28081796-27551411-5391-4643-8180-DD07B804E40BQ33654679-CA34A9C7-D0F4-4062-86E2-722E5DE1645AQ35225411-0A4B60A6-D1B1-4521-9F83-FCC420E41922Q36226309-8C0D1619-E08E-4BDA-A68C-368593D8BD2AQ38537109-6E7E2B13-3393-4DF2-87F8-7D7588208BFAQ38931121-8D9DEC2E-5A9D-4F71-9F6E-2FA45AA160E8Q46611022-5499352D-DA28-4EC2-A522-5B5143F1F286Q47309333-0A3A8E7C-2B96-48DB-A03E-FF8073175796
P2860
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilars.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Active and passive surveillanc ...... study relevant to biosimilars.
@ast
Active and passive surveillanc ...... study relevant to biosimilars.
@en
type
label
Active and passive surveillanc ...... study relevant to biosimilars.
@ast
Active and passive surveillanc ...... study relevant to biosimilars.
@en
prefLabel
Active and passive surveillanc ...... study relevant to biosimilars.
@ast
Active and passive surveillanc ...... study relevant to biosimilars.
@en
P2093
P2860
P1476
Active and passive surveillanc ...... study relevant to biosimilars.
@en
P2093
Gustavo Grampp
J Michael Sprafka
Machaon Bonafede
Michael Malecki
Thomas Felix
P2860
P304
P356
10.1517/14740338.2015.1001364
P407
P577
2015-01-05T00:00:00Z